Anlotinib Hydrochloride and PD-1 Blockade as a Salvage Second-Line Treatment in Patients with Progress of Local Advanced Non-Small Cell Lung Cancer in Half a Year After Standard Treatment

PURPOSE: As for local advanced non-small cell lung cancer (NSCLC), synchronous radiotherapy and chemotherapy is the standard treatment mode. But for patients with progress in half a year, which means the second-line chemotherapy effect is not ideal for them. We observed the efficacy and safety of an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Chengqi, Jiang, Leilei, Yang, Dan, Dong, Xin, Yu, Rong, Yu, Huiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575589/
https://www.ncbi.nlm.nih.gov/pubmed/36262804
http://dx.doi.org/10.2147/OTT.S380615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575589/
https://www.ncbi.nlm.nih.gov/pubmed/36262804
http://dx.doi.org/10.2147/OTT.S380615

Ejemplares similares